Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphoma

BACKGROUND: Treatment of central nervous system relapse in adult acute lymphoblastic leukemia is a challenge and outcome is poor. Liposomal cytarabine has a prolonged half-life and, given intrathecally, has produced high response rates in patients with central nervous system relapse of non-Hodgkin&#...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Gökbuget, Nicola, Hartog, Christina-Maria, Bassan, Renato, Derigs, Heinz-Gerd, Dombret, Herve, Greil, Richard, Hernández-Rivas, Jesus-Maria, Huguet, Francoise, Intermesoli, Tamara, Jourdan, Eric, Junghanss, Christian, Leimer, Lothar, Moreno, Maria-Jose, Reichle, Albrecht, Ribera, Josep, Schmid, Matthias, Serve, Hubert, Stelljes, Matthias, Stuhlmann, Reingard, Hoelzer, Dieter
Format: Artigo
Idioma:Inglês
Publicat: Ferrata Storti Foundation 2011
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3031691/
https://ncbi.nlm.nih.gov/pubmed/20952517
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2010.028092
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars